Status:
COMPLETED
Skin Autofluorescence (AF) Decision Tree in Detecting Impaired Glucose Tolerance (IGT) or Diabetes Mellitus (DM)
Lead Sponsor:
University Medical Center Groningen
Conditions:
Diabetes Mellitus
Impaired Glucose Tolerance
Eligibility:
All Genders
20+ years
Brief Summary
Early detection of (pre)diabetes, including impaired glucose tolerance is currently deficient because the best accepted standard, an oral glucose tolerance test (oGTT), is not feasible in a setting of...
Eligibility Criteria
Inclusion
- age \>20 years
- additionally a priori intermediate risk for IGT/diabetes: by having at least one criterion from the metabolic syndrome, or by at least once having had an increased glucose or glycated hemoglobin value in the preceding two years, but these outside the range of diabetes/IGT
Exclusion
- known diabetes mellitus
- use of oral antidiabetics for other purposes than diabetes such as hepatic steatosis
- local skin disease of the lower arm obviating skin autofluorescence measurement
- known serious renal insufficiency (s-creatinine \> 180 umol/l).
- inability to fill in questionnaires
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT01406665
Start Date
October 1 2010
End Date
April 1 2011
Last Update
August 1 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gelre Ziekenhuis
Apeldoorn, Gelderland, Netherlands, 7334 DZ
2
University Medical Center Groningen
Groningen, Provincie Groningen, Netherlands, 9700 RB